Clinical Trial

Scapular Muscle Activation and Shoulder Performance in Migraine

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 18, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Migraine is a significant health problem due to its high prevalence and substantial contribution to disability. Individuals with migraine have been reported to exhibit myofascial trigger points, increased pain sensitivity, and altered muscle activation patterns, particularly in the trapezius muscles. As the upper and middle trapezius muscles play critical roles in scapular stability and movement, alterations in these muscles may affect scapular orientation and upper extremity function. However, studies investigating the relationship between trapezius muscle activation, scapular orientation, and upper extremity performance in individuals with migraine are limited. Therefore, this study aimed to compare trapezius muscle activation, scapular orientation, and upper extremity performance between individuals with and without migraine. We hypothesized that individuals with migraine would exhibit altered upper and middle trapezius muscle activation, impaired scapular orientation, and reduced upper extremity performance compared with healthy controls.
Trial Details
NCT Number NCT07656922
Lead Sponsor Ankara Yildirim Beyazıt University
Conditions Migraine, Upper Extremity, Muscle Activity
Enrollment 50 participants
Start Date 2026-04-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-18